Real Alternatives The concession that competitors rarely make: for joint and tendon repair goals, current evidence does not support BPC-157 capsules over established physiotherapy plus approved adjuncts

By blocking SGLT2: Glucose reabsorption Urinary glucose excretion Blood glucose levels Benefits beyond glucose control: Reduced risk of hospitalization for heart failure Slowing progression of chronic kidney disease Cardiovascular protection in selected patients Mild weight reduction and blood pressure benefits Examples: Empagliflozin Dapagliflozin Canagliflozin Important counseling points: Maintain adequate hydration Monitor for symptoms of urinary/genital infections Be aware of rare risk of diabetic ketoacidosis Regular monitoring of kidney function is essential The pharmacists role: Pharmacists play an important role in: Patient education Medication safety monitoring Improving adherence Identifying adverse effects early Key takeaway: SGLT2 inhibitors represent a shift from treating a number (blood glucose) to protecting the patient as a whole heart, kidneys, and overall health

Colonoscopy-based colorectal cancer modeling in mice with CRISPRCas9 genome editing and organoid transplantation
Wang, M., Zhang, G., Zhang, D., Zhu, D
Y., Nishida, T., Ogawa, W., Tobe, K., Yamauchi, T., & Lim, S